A case report of prostate rhabdomyosarcoma

[1]

WU Wen, ZHANG Ruoxin, WENG Junyong, MA Yanlei, CAI Guoxiang, LI Xinxiang, YANG Yongzhi. Exploring the prognostic value of positive lymph node ratio in stage Ⅲ colorectal cancer patients and establishing a predictive model [J]. China Oncology, 2024, 34(9): 873-880.

[2]

Committee of Integrated Rehabilitation for Urogenital Tumors, Chinese Anti-Cancer Association. Chinese expert consensus on perioperative integrated rehabilitation for radical prostatectomy (2024 edition) [J]. China Oncology, 2024, 34(9): 890-902.

[3]

XIAO Feng, XU Tonglin, ZHU Lin, XIAO Jingwen, WU Tianqi, GU Chunyan. Significance of infiltration of M1 tumor-associated macrophages in hepatocellular carcinoma [J]. China Oncology, 2024, 34(8): 726-733.

[4]

Cancer Assessment Society of China Anti-Cancer Association, Cancer Pain Society of Fujian Anti-Cancer Association. Chinese expert consensus on whole-process management of oxaliplatin-induced hypersensitivity reactions (2024 edition) [J]. China Oncology, 2024, 34(8): 785-805.

[5]

[6]

[7]

Cancer Nuclear Medicine Committee of China Anti-Cancer Association, Chinese Association of Nuclear Medicine Physicians. Expert consensus of ¹⁷⁷Lu-labeled PSMA radioligand therapy for clinical practice of prostate cancer (2024 edition) [J]. China Oncology, 2024, 34(7): 702-714.

[8]

[9]

Urologic Chinese Oncology Group. Expert consensus on early diagnosis and treatment of bladder cancer (2024 edition) [J]. China Oncology, 2024, 34(6): 607-618.

[10]

ZHANG Ruoxin, YE Zilan, WENG Junyong, LI Xinxiang. Correlation study between advanced age and inferior prognosis in stage Ⅱ colorectal cancer patients [J]. China Oncology, 2024, 34(5): 485-492.

[11]

Professional Committee on Gastric Cancer of Shanghai Anticancer Association , Professional Committee on Gastrointestinal Cancer of China Association for Promotion of Health Science and Technology . Chinese expert consensus on clinical practice of locally advanced gastric cancer invading adjacent organs (2024 edition) [J]. China Oncology, 2024, 34(5): 517-526.

[12]

FENG Zheng, GUO Qinhao, ZHU Jun, WU Xiaohua, WEN Hao. Progress in treatment of gynecological cancer in 2023 [J]. China Oncology, 2024, 34(4): 340-360.

[13]

XU Yonghu, XU Dazhi. Progress and prospects of gastric cancer treatment in the 21st century [J]. China Oncology, 2024, 34(3): 239-249.

[14]

WANG Xuefei, ZHOU Peng, TANG Zhaoqing. New progress and development trend of surgical treatment for gastric cancer [J]. China Oncology, 2024, 34(3): 250-258.

[15]

PDF